Financials
- Market Capitalization 374.91 M
- Employee 22
- Founded 2017
- CEO N/A
- Website www.q32bio.com
- Headquarter Delaware, United States
- FIGI BBG00CTTJWQ9
- Industry Case Farmaceutiche - Generali
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
1.37
Rapporto prezzo/fatturato
0.76
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3029 | CBIO Crescent Biopharma, Inc. - Common Stock | 15.72 USD | +0.19% | -5.47% | -11.83% | +22.81% | 433.43 M USD | ||
| 3120 | UPB Upstream Bio, Inc. - Common Stock | 7.21 USD | -0.96% | -7.21% | +16.48% | -38.90% | 392.37 M USD | ||
| 3338 | AMRN Amarin Corporation plc - American Depositary Shares, each repre | 14.59 USD | -0.75% | -3.82% | -4.64% | -6.23% | 305.94 M USD | ||
| 3741 | OKUR OnKure Therapeutics, Inc. - Class A Common Stock | 4.24 USD | +3.16% | -1.85% | +2.91% | +73.06% | 171.28 M USD |